UnitedHealth Group stock at EUR 370.00, up 2.89% premarket
Published on 11/04/2026 at 08:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSInvestor calendar and risk focus
- UnitedHealth Group's investor calendar lists no upcoming events.
- The latest investor news includes third-quarter 2026 results, an earnings release date announcement and a board authorization for a quarterly dividend.
- Medical costs, healthcare regulation and the Department of Justice's legal actions are among the risks highlighted by the company.
UnitedHealth Group stock traded at EUR 370.00 on Lang & Schwarz at 08:32 CET on Wednesday, November 4, 2026, 2.89% above the Xetra close of Tuesday, November 3, 2026, at EUR 359.60; the real-time quote of UnitedHealth Group stock is available here.
UnitedHealth Group investor relations lists no upcoming events. Its latest investor news includes third-quarter 2026 results, an earnings release date announcement and a board authorization for payment of a quarterly dividend.
Risks remain central for investors
The company highlights medical-cost management, changes in healthcare laws and regulation, Medicare-related developments, cybersecurity and litigation among factors that could affect results. It also cites the Department of Justice's legal actions concerning its participation in the Medicare program.
For the broader US market, investors can follow the S&P 500.
More news and analyses on UnitedHealth Group stock remain available for investors tracking medical costs, regulation and company execution.
